These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. "Out of the blue"-safety and efficacy of pulmonary hypertension treatment in childhood*. Kraemer U, Wildschuth E, Tibboel D. Pediatr Crit Care Med; 2014 May; 15(4):377-8. PubMed ID: 24801422 [No Abstract] [Full Text] [Related]
13. An in vitro and in vivo comparative study of directly compressed solid dispersions and freeze dried sildenafil citrate sublingual tablets for management of pulmonary arterial hypertension. Zayed R, Kamel AO, Shukr M, El-Shamy Ael-H. Acta Pharm; 2012 Nov; 62(3):411-32. PubMed ID: 23470352 [Abstract] [Full Text] [Related]
15. Effects of escalating doses of sildenafil on hemodynamics and gas exchange in children with pulmonary hypertension and congenital cardiac defects. Raja SG, Danton MD, MacArthur KJ, Pollock JC. J Cardiothorac Vasc Anesth; 2007 Apr; 21(2):203-7. PubMed ID: 17418732 [Abstract] [Full Text] [Related]
16. [Oral sildenafil for pulmonary hypertension in neonates]. Gutiérrez Nicolás F, Viña Romero MM, González Carretero P, Merino Alonso J. Farm Hosp; 2011 Apr; 35(3):157-8. PubMed ID: 21439880 [No Abstract] [Full Text] [Related]
19. Nebulization performance of biodegradable sildenafil-loaded nanoparticles using the Aeroneb Pro: formulation aspects and nanoparticle stability to nebulization. Beck-Broichsitter M, Kleimann P, Gessler T, Seeger W, Kissel T, Schmehl T. Int J Pharm; 2012 Jan 17; 422(1-2):398-408. PubMed ID: 22001839 [Abstract] [Full Text] [Related]